Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Appel

Showing results (421-430 of 455) with videos related to

Pageof 46
Sort By:
Biochemical and Biophysical Research Communications|September 3, 2009
Abnormal serum concentrations of proteins in Parkinson's diseaseIra L Goldknopf, Jennifer K Bryson, Irina Strelets, et al.
Nature Communications|September 5, 2024
Deterministic photon source of genuine three-qubit entanglementYijian Meng, Ming Lai Chan, Rasmus B Nielsen, et al.
Cytotherapy|August 8, 2016
A robust, good manufacturing practice-compliant, clinical-scale procedure to generate regulatory T cells from patients with amyotrophic lateral sclerosis for adoptive cell therapyAbdullah Alsuliman, Stanley H Appel, David R Beers, et al.
Neurology|October 22, 2008
Hematopoietic stem cell transplantation in patients with sporadic amyotrophic lateral sclerosisS H Appel, J I Engelhardt, J S Henkel, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|August 29, 2022
Combined Regulatory T-Lymphocyte and IL-2 Treatment Is Safe, Tolerable, and Biologically Active for 1 Year in Persons With Amyotrophic Lateral SclerosisJason R Thonhoff, James D Berry, Eric A Macklin, et al.
British Journal of Cancer|July 29, 2017
TCTP as a therapeutic target in melanoma treatmentM Boia-Ferreira, A B Basílio, A E Hamasaki, et al.
Translational Neurodegeneration|November 16, 2023
A phase 1 open-label pilot study of low-dose interleukine-2 immunotherapy in patients with Alzheimer's diseaseAlireza Faridar, Abdulmunaim M Eid, Aaron D Thome, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|January 9, 2018
An open label study of a novel immunosuppression intervention for the treatment of amyotrophic lateral sclerosisChristina N Fournier, David Schoenfeld, James D Berry, et al.
Genes & Development|May 22, 2025
Epigenetic priming of neural progenitors by Notch enhances Sonic hedgehog signaling and establishes gliogenic competenceLuuli N Tran, Ashwini Shinde, Kristen H Schuster, et al.
Biorxiv : the Preprint Server for Biology|February 3, 2025
Epigenetic priming of neural progenitors by Notch enhances Sonic hedgehog signaling and establishes gliogenic competenceLuuli N Tran, Ashwini Shinde, Kristen H Schuster, et al.
Pageof 46

Showing results (421-430 of 455) with videos related to

Sort By:
Pageof 46
Biochemical and Biophysical Research Communications|September 3, 2009
Abnormal serum concentrations of proteins in Parkinson's diseaseIra L Goldknopf, Jennifer K Bryson, Irina Strelets, et al.
Nature Communications|September 5, 2024
Deterministic photon source of genuine three-qubit entanglementYijian Meng, Ming Lai Chan, Rasmus B Nielsen, et al.
Cytotherapy|August 8, 2016
A robust, good manufacturing practice-compliant, clinical-scale procedure to generate regulatory T cells from patients with amyotrophic lateral sclerosis for adoptive cell therapyAbdullah Alsuliman, Stanley H Appel, David R Beers, et al.
Neurology|October 22, 2008
Hematopoietic stem cell transplantation in patients with sporadic amyotrophic lateral sclerosisS H Appel, J I Engelhardt, J S Henkel, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|August 29, 2022
Combined Regulatory T-Lymphocyte and IL-2 Treatment Is Safe, Tolerable, and Biologically Active for 1 Year in Persons With Amyotrophic Lateral SclerosisJason R Thonhoff, James D Berry, Eric A Macklin, et al.
British Journal of Cancer|July 29, 2017
TCTP as a therapeutic target in melanoma treatmentM Boia-Ferreira, A B Basílio, A E Hamasaki, et al.
Translational Neurodegeneration|November 16, 2023
A phase 1 open-label pilot study of low-dose interleukine-2 immunotherapy in patients with Alzheimer's diseaseAlireza Faridar, Abdulmunaim M Eid, Aaron D Thome, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|January 9, 2018
An open label study of a novel immunosuppression intervention for the treatment of amyotrophic lateral sclerosisChristina N Fournier, David Schoenfeld, James D Berry, et al.
Genes & Development|May 22, 2025
Epigenetic priming of neural progenitors by Notch enhances Sonic hedgehog signaling and establishes gliogenic competenceLuuli N Tran, Ashwini Shinde, Kristen H Schuster, et al.
Biorxiv : the Preprint Server for Biology|February 3, 2025
Epigenetic priming of neural progenitors by Notch enhances Sonic hedgehog signaling and establishes gliogenic competenceLuuli N Tran, Ashwini Shinde, Kristen H Schuster, et al.
Pageof 46